Consultation responses on the Reimbursement Committee’s recommendation concerning the reimbursement status of medicinal products in ATC group A02 (drugs for acid related disorders)

The Reimbursement Committee’s recommendation concerning the future reimbursement status of medicinal products in ATC group A02 (drugs for acid related disorders) was open for consultation until 15 March 2010.

The Danish Medicines Agency received seven consultation responses. The factbox to the right contains links to the consultation responses (in Danish only) and the Danish Medicines Agency’s announcement of 15 December 2009, where you can also find the Reimbursement Committee’s recommendation.

The Danish Medicines Agency now deliberates to reach a decision.

For further information, please contact the Reimbursement Department: Send an email.  

Danish Medicines Agency, 7 April 2010